Literature DB >> 11642377

Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy.

N G Ghazi1, N M Jabbour, Z C De La Cruz, W R Green.   

Abstract

BACKGROUND: Photodynamic therapy (PDT) is a relatively new modality that is currently under clinical and experimental evaluation for treatment of subfoveal choroidal neovascularization (CNV). The authors report the case of an 82-year-old woman who underwent verteporfin-mediated PDT for classic subfoveal CNV. Fluorescein angiography performed 2 weeks after treatment disclosed reduction of the initial area of neovascularization and leakage by approximately 60%. Three weeks after PDT, however, the area of leakage was almost the same size as that before treatment. The patient underwent submacular membranectomy almost 4 weeks after treatment. The authors describe the ultrastructural vascular changes after PDT and a clinicopathologic study of classic CNV.
METHODS: The submacular membrane was studied by light and electron microscopy and immunohistochemical techniques.
RESULTS: Ultrastructural examination of the peripheral vessels showed evidence of endothelial cell degeneration with platelet aggregation and thrombus formation. Occasional occluded vessels were surrounded by macrophages, a phenomenon previously reported to describe the process of resorption of such blood vessels. The vessels in the center of the membrane were unremarkable.
CONCLUSION: Photodynamic therapy causes endothelial cell damage, thrombus formation, and vascular occlusion of classic CNV in age-related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11642377     DOI: 10.1097/00006982-200110000-00010

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  16 in total

1.  The changes of multifocal electroretinography in the early stage of photodynamic therapy for choroidal neovascularization.

Authors:  Libin Jiang; Chenjin Jin; Feng Wen; Shizhou Huang; Dezheng Wu; Lezheng Wu
Journal:  Doc Ophthalmol       Date:  2003-09       Impact factor: 2.379

2.  Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.

Authors:  M B Parodi; S Da Pozzo; G Ravalico
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

3.  Macular relocation after photodynamic therapy for recurrent choroidal neovascular membrane: visual results and histopathological findings.

Authors:  P Stanga; P Hiscott; K Li; D Wong
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

4.  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Amy L Wong; David T L Liu; Dennis S C Lam
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

5.  Photodynamic therapy with verteporfin for retinal angiomatous proliferation.

Authors:  Francesco Boscia; Maurizio Battaglia Parodi; Claudio Furino; Michele Reibaldi; Carlo Sborgia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-09       Impact factor: 3.117

6.  Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study.

Authors:  J Sahni; P Stanga; D Wong; S Harding
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

Review 7.  Spotlight on verteporfin in subfoveal choroidal neovascularisation.

Authors:  Susan J Keam; Lesley J Scott; Monique P Curran
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

8.  Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy.

Authors:  F Gelisken; B A Lafaut; W Inhoffen; M Voelker; S Grisanti; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

9.  Histopathological findings in postmortem eyes after photodynamic therapy for choroidal neovascularisation in age-related macular degeneration: report of two cases.

Authors:  S J Kang; I Schmack; H E Benson; H E Grossniklaus
Journal:  Br J Ophthalmol       Date:  2007-06-13       Impact factor: 4.638

10.  Changes in visual function and thickness of macula after photodynamic therapy for age-related macular degeneration.

Authors:  Kyoko Okada; Mariko Kubota-Taniai; Masayasu Kitahashi; Takayuki Baba; Yoshinori Mitamura; Shuichi Yamamoto
Journal:  Clin Ophthalmol       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.